Cromolyn Sodium Dosing
Cromolyn sodium is dosed at 20 mg (one capsule or ampule) four times daily via nebulizer or metered-dose inhaler for asthma, or one spray per nostril 3-6 times daily (every 4-6 hours) for allergic rhinitis. 1
Important Clarification on Drug Classification
Cromolyn sodium is not an inhaled corticosteroid—it is a mast cell stabilizer with an entirely different mechanism of action. 2 This is a critical distinction that affects prescribing decisions and patient counseling.
Asthma Dosing
Standard Maintenance Therapy
- Adults and children ≥5 years: 20 mg four times daily via nebulizer solution or 2 puffs (2 mg per puff) four times daily via metered-dose inhaler 1, 3
- Children 0-4 years: Nebulizer delivery is the preferred method in young children who cannot coordinate MDI use 1
Exercise-Induced Bronchospasm
- Single prophylactic dose: One dose 15-30 minutes before exercise or allergen exposure provides effective prophylaxis for 1-2 hours 1
- This is less effective than short-acting beta-agonists for exercise-induced bronchospasm 1
Clinical Role in Asthma Management
- Cromolyn is positioned as an alternative (not preferred) therapy for Step 2 mild persistent asthma in patients unable or unwilling to use inhaled corticosteroids 1
- The preferred Step 2 treatment remains low-dose inhaled corticosteroids 1
- A 4-6 week trial is required to determine maximum benefit, as onset of action is prolonged 1
- Once control is achieved, dosing frequency may be reduced 1
Allergic Rhinitis Dosing
Over-the-Counter Nasal Spray (4% Solution)
- Standard dosing: One spray in each nostril every 4-6 hours, maximum 6 times daily 4
- Begin use before allergen exposure for optimal prevention 4
- Treatment duration of at least 2 weeks is recommended for full assessment of efficacy 4, 5
Oral Formulation for Food-Induced Rhinitis
- Dosing: 200 mg orally four times daily, starting 3 days before anticipated food exposure and continuing 3 days after 6
- This formulation is effective for preventing immediate and late nasal responses to ingested foods 6
Critical Dosing Considerations
Delivery Device Matters
- MDI doses may be inadequate to affect bronchial hyperresponsiveness in some patients 1
- Nebulizer delivery provides more consistent dosing, particularly in young children and during acute symptoms 1
- Large volume spacer devices should be used with MDIs to enhance delivery 1
Timing and Frequency
- Four times daily dosing is essential for maintenance asthma therapy—less frequent dosing is inadequate 1, 3
- For rhinitis, the every 4-6 hours schedule must be maintained for symptom control 4
- Prophylactic use before known triggers is more effective than reactive treatment 1
Response Assessment Timeline
- Do not abandon therapy prematurely: 4-6 weeks of consistent use is required before concluding treatment failure 1
- In children 0-4 years, if no clear benefit is observed within 4-6 weeks, discontinue and consider alternative diagnoses 1
Common Pitfalls to Avoid
- Do not use cromolyn for acute symptom relief—it has no bronchodilator properties and is purely prophylactic 1, 2
- Do not substitute cromolyn for inhaled corticosteroids in patients with moderate-to-severe asthma—it is substantially less effective 1
- Do not expect immediate results—the prolonged onset of action means patients must continue therapy for weeks before assessing efficacy 1
- Do not underdose—four times daily administration is required for asthma; less frequent dosing will fail 1, 3
Safety Profile
Cromolyn has an extremely low frequency of adverse effects at standard doses, with toxicity being mild, short-lived, and without sequelae. 2 The most common side effects are headache and rhinitis, occurring at rates similar to placebo. 4